Featured Research

from universities, journals, and other organizations

Multi Drug Resistant-TB: Russian Economic Collapse Will Lead To Global Spread Of "Ebola With Wings"

Date:
September 16, 1998
Source:
Noonan/Russo Communications
Summary:
The Public Health Research Institute, Doctors Without Borders (Medicins sans Frontiers) and the Medical Emergency Relief Network International (MERLIN) have issued a joint statement about the need for international attention and support to combat the epidemic of drug-resistant tuberculosis (MDR-TB) in Russia, which is threatening to become a global problem.

The Public Health Research Institute, Doctors Without Borders (Medecins sans Frontiers) and the Medical Emergency Relief Network International (MERLIN) have issued a joint statement about the need for international attention and support to combat the epidemic of drug-resistant tuberculosis (MDR-TB) in Russia, which is threatening to become a global problem.

Referring to the disease as "Ebola with Wings," the organizations released their plea after members of the PHRI/Soros TB Advisory Committee toured prisons in Tomsk and Kemerovo the week Sept. 7. PHRI has begun pilot programs in prisons in Tomsk, Ivanovo and Marii El as part of a $12.3 million project funded by philanthropist George Soros to combat TB in Russia. Before their tour, PHRI and the Russian Ministry of Health hosted the International Workshop on TB in Russia on Monday, Sept. 7, 1998 to address the serious public health problem.

Following is the statement from three organizations. For additional information about PHRI, the PHRI/Soros project, TB in Russia and globally or the disease in general, please visit: http://www.noonanrusso.com/www/phri.

For more information or to arrange an interview with the director of the PHRI/Soros project, please call Noonan/Russo Communications at 212-696-4455 and ask for Ernie Knewitz, x 204, Marion E. Glick, x 221 or Tony Russo at x202.

Statement by

Doctors Without Borders (Medecins sans Frontiers), the Medical Emergency Relief Network International (MERLIN) and The Public Health Research Institute

Multi Drug Resistant-TB: Russian Economic Collapse will Lead to Global Spread of "Ebola with Wings"

Foreign Funds are Needed to Prevent Epidemic

Our three nongovernmental organizations are calling for an urgent worldwide campaign to raise the $100 million needed to prevent the imminent epidemic of multidrug resistant tuberculosis (MDR-TB) in Russia. In our view, this local humanitarian disaster is already a direct global public health threat.

Drug-senstive TB is curable through proper drug therapy. MDR-TB is potentially much more dangerous, especially because TB spreads through the air and can move from patient to patient in its deadly drug-resistant form. MDR-TB has been dubbed "Ebola with wings."

Current levels of MDR-TB in Russia are alarming. The looming economic crisis will exacerbate the problem. It is only a matter of time before MDR-TB of Russian origin becomes a daily reality in other countries worldwide.

The current Russian economic crisis will further deplete already strained resources of public medicine. The resulting shortage of anti-TB drugs will inevitably lead to the massive practice of substandard antibiotic treatment of patients with TB, which is the principal cause of MDR-TB. Standard treatment of regular TB consists of a daily regimen of four different antibiotics for six months. When this treatment is incomplete or interrupted, a patient can easily develop MDR-TB and then spread this potentially lethal form of TB to other people.

We are particularly concerned about the dire situation in Russian prisons, where systematic underfunding combined with epidemic-prone conditions already has resulted in the generation of nearly 20,000 MDR-TB cases. The number of cases is expected to rise because, under the current conditions, about 100,000 inmates with regular TB are subjected to inappropriate, MDR-causing treatment protocols.

Among the civilian population, TB patients undergoing treatment often are required to pay for their own drugs, even in state run hospitals. In the worsening economic situation, this burden on patients will translate into inadequate treatment and, consequently, thousands of new MDR-TB cases because most people will discontinue prescribed treatment as soon as symptoms subside.

Our activities in several pilot projects in Russia convinced us that an effective anti-TB program can be implemented nationwide, but only through cooperation among foreign health agencies and Russian health authorities. Alone, Russia will not have the needed resources to cope with this problem.

We are calling on the world community to provide funds needed to bring the Russian epidemics of TB and MDR-TB under control. The minimum estimate for a nationwide emergency program is $100 million. This cost is small in comparison to the loss of life and potential global economic damage that can be anticipated in the near future if the problem of MDR-TB in Russia is not addressed today.


Story Source:

The above story is based on materials provided by Noonan/Russo Communications. Note: Materials may be edited for content and length.


Cite This Page:

Noonan/Russo Communications. "Multi Drug Resistant-TB: Russian Economic Collapse Will Lead To Global Spread Of "Ebola With Wings"." ScienceDaily. ScienceDaily, 16 September 1998. <www.sciencedaily.com/releases/1998/09/980916074355.htm>.
Noonan/Russo Communications. (1998, September 16). Multi Drug Resistant-TB: Russian Economic Collapse Will Lead To Global Spread Of "Ebola With Wings". ScienceDaily. Retrieved September 18, 2014 from www.sciencedaily.com/releases/1998/09/980916074355.htm
Noonan/Russo Communications. "Multi Drug Resistant-TB: Russian Economic Collapse Will Lead To Global Spread Of "Ebola With Wings"." ScienceDaily. www.sciencedaily.com/releases/1998/09/980916074355.htm (accessed September 18, 2014).

Share This



More Health & Medicine News

Thursday, September 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Artificial Sweetener Could Promote Diabetes

Artificial Sweetener Could Promote Diabetes

Newsy (Sep. 17, 2014) Doctors once thought artificial sweeteners lacked the health risks of sugar, but a new study says they can impact blood sugar levels the same way. Video provided by Newsy
Powered by NewsLook.com
Ebola Vaccine Trial Gets Underway at Oxford University

Ebola Vaccine Trial Gets Underway at Oxford University

AFP (Sep. 17, 2014) A healthy British volunteer is to become the first person to receive a new vaccine for the Ebola virus after US President Barack Obama called for action against the epidemic and warned it was "spiralling out of control." Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Obesity Rates Steady Even As Americans' Waistlines Expand

Obesity Rates Steady Even As Americans' Waistlines Expand

Newsy (Sep. 17, 2014) Researchers are puzzled as to why obesity rates remain relatively stable as average waistlines continue to expand. Video provided by Newsy
Powered by NewsLook.com
President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins